Regulation of Pancreatic Development and Disease By Pancreas Transcription Factor 1 (PTF1) Complex

Target Name: Pancreas transcription factor 1 complex

NCBI ID: P15799

Pancreas transcription factor 1 complex

Other Name(s): None

Regulation of Pancreatic Development and Disease By Pancreas Transcription Factor 1 (PTF1) Complex

The Pancreas transcription factor 1 (PTF1) complex is a protein that plays a crucial role in pancreatic development, function, and disease. It is a transcription factor that regulates the expression of genes in the pancreatic gland, and its abnormalities can lead to a range of pancreatic disorders, including type 1 diabetes, obesity, and pancreatic cancer.

The PTF1 complex is a complex of four proteins that work together to control gene expression in the pancreatic gland. The four proteins are PTF1 itself, along with its interacting proteins PDZF2, casein kinase 7 (CK7), and Myosin.

PTF1 is a transcription factor that plays a central role in the regulation of gene expression in the pancreatic gland. It is a 22 kDa protein that consists of an N-terminal domain that contains a nuclear localization signal, a transmembrane domain, and a C- terminal domain that contains a protein-coding region. The N-terminal domain contains a critical N-terminal hypervariable region (HVR) that is involved in the formation of the complex.

The PTF1 complex functions as a transcriptional regulator by binding to specific DNA sequences in the target gene. It does this through its N-terminal HVR, which is able to interact with the core binding site (CBS) of the transcription factor. The CBS is a specific protein that is located in the nucleus and is involved in the regulation of gene expression. It is composed of two subunits, alpha and beta, that are held together by a disulfide bond.

The PTF1 complex is able to form a stable complex with the CBS through its N-terminal HVR. This allows the PTF1 protein to interact with the CBS and regulate the activity of the transcription factor. The PTF1 complex is also able to form a separate complex with the beta subunit of the CBS, which is called the pilin-CBS complex (PBC).

The PBC is a protein that is composed of the alpha subunit of the PSF2 protein and the beta subunit of the CK7 protein. It is a 21 kDa protein that is involved in the regulation of gene expression in the pancreatic gland. It is able to interact with the PTF1 complex through its N-terminal region, which is able to interact with the PTF1 HVR. This allows the PBC to regulate the activity of the PTF1 complex and control gene expression in the pancreatic gland.

The PTF1 complex is also involved in the regulation of pancreatic cancer. It is has been shown to be involved in the development and progression of pancreatic cancer, and it is also a potential drug target for this disease.

In conclusion, the Pancreas transcription factor 1 (PTF1) complex is a protein that plays a crucial role in pancreatic development, function, and disease. It is a transcription factor that regulates the expression of genes in the pancreatic gland, and its abnormalities can lead to a range of pancreatic disorders, including type 1 diabetes, obesity, and pancreatic cancer. The PTF1 complex is also a potential drug target for these diseases, and it is a target that researchers are actively working on developing new treatments.

Protein Name: Pancreas Transcription Factor 1 Complex

The "Pancreas transcription factor 1 complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Pancreas transcription factor 1 complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets